News | February 05, 2009

ZOLL Files Suit Against Alsius Over Induced Hypothermia Patents

February 5, 2009 - Resuscitation device maker ZOLL Medical Corp. said this week it filed a lawsuit against Alsius Corp. and Alsius Medical Corp. in the Central District of California alleging infringement of its patents for catheter-based induced hypothermia devices.

Zoll does not currently have any induced hypothermia products on the market using these patents, but alleges Alsius violated two Zoll patents for such a device. Induced hypothermia is used to help stabilize patients suffering from sever trauma or cardiac arrest.

ZOLL Medical develop technologies that help advance resuscitation, with products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

Alsius offers the Intravascular Temperature Management (IVTM) Thermogard XP, which uses a catheter is inserted into the central venous system of a critically ill or surgical patient (femoral, subclavian, or internal jugular insertion). Temperature is regulated with cooled or warmed saline circulating through the catheter balloons.

For more information: visit www.zoll.com

Related Content

therapeutic hypothermia, children, cardiac arrest, treatment, temperature
Feature | May 04, 2015
A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain...
News | December 11, 2014
Researchers at Okayama University in collaboration with several medical centers in Japan have demonstrated the safety...
Feature | September 19, 2014
September 19, 2014 — According to a new study, peritoneal hypothermia is feasible for patients who have suffered ST-...
Technology | July 10, 2014
July 10, 2014 — Life Recovery Systems announced the U.S. Food and Drug Administration (FDA) has approved two...
therapeutic hypothermia, Philips InnerCool

The Philips InnerCool RTx system was used in the CHILL-MI study for use in STEMI patients.

Feature | February 03, 2014 | Dave Fornell
Use of therapeutic hypothermia is used to prevent neurological damage in patients who suffer sudden cardiac arrest (SCA...
BeneChill RhinoChill Therapeutic Hypothermia Cath Lab Intranasal Cooling System
News | January 22, 2014
BeneChill Inc. received the 2014 Frost & Sullivan Award for Technology Innovation Leadership for its RhinoChill...
rhinochill, RhinoChill, benechill, BeneChill

RhinoChill IntraNasal Cooling System

News | December 03, 2013
With the benefits of conventional strategies for therapeutic hypothermia following cardiac arrest being called in to ...
therapeutic hypothermia temperature management cath lab clinical trial study
Feature | November 01, 2013
clinical trial shows that rapidly cooling...
News | October 01, 2013
The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that...
News | August 06, 2013
Vanderbilt Heart and Vascular Institute is participating in the VELOCITY study, a randomized controlled clinical study...
Overlay Init